SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ersilia M. DeFilippis, Sonal Kumar, Clinical Presentation and Outcomes of Autoimmune Hepatitis in Inflammatory Bowel Disease, Digestive Diseases and Sciences, 2015,

    CrossRef

  2. 2
    Matthew R. Smith, Sheldon C. Cooper, Mycophenolate mofetil therapy in the management of inflammatory bowel disease — A retrospective case series and review, Journal of Crohn's and Colitis, 2014, 8, 8, 890

    CrossRef

  3. 3
    P. Azevedo, C. Freitas, P. Aguiar, H. Silva, T. Santos, P. Farrajota, M. Almeida, S. Pedroso, L.S. Martins, L. Dias, R. Vizcaíno, A. Castro Henriques, A. Cabrita, A Case Series of De Novo Inflammatory Bowel Disease After Kidney Transplantation, Transplantation Proceedings, 2013, 45, 3, 1084

    CrossRef

  4. 4
    Marie-France Dubeau, Marietta Iacucci, Paul L. Beck, Gordon W. Moran, Gilaad G. Kaplan, Subrata Ghosh, Remo Panaccione, Drug-induced inflammatory bowel disease and IBD-like conditions, Inflammatory Bowel Diseases, 2012, 18, 12
  5. You have free access to this content5
    A. Sandhu, T. Alameel, C. H. Dale, M. Levstik, N. Chande, The safety and efficacy of antitumour necrosis factor-alpha therapy for inflammatory bowel disease in patients post liver transplantation: a case series, Alimentary Pharmacology & Therapeutics, 2012, 36, 2
  6. 6
    Antony Pan, Martin Schlup, Ralf Lubcke, Michael Schultz, Fulminant ulcerative colitis despite maximal immunosuppression following liver transplantation: A case report and literature review, Journal of Crohn's and Colitis, 2011, 5, 5, 465

    CrossRef

  7. 7
    E. McDermott, D. Keegan, B. Hall, E. N. Mhuruchu, S. Murphy, G. Doherty, D. O’Donoghue, H. Mulcahy, Mycophenolate mofetil following intolerance or failure of thiopurine therapy in inflammatory bowel diseases, Alimentary Pharmacology & Therapeutics, 2011, 34, 8
  8. 8
    Mark T. Osterman, Gary R. Lichtenstein, Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 2010,

    CrossRef

  9. 9
    Sutapa Ford, Alan G. Finkel, Kim L. Isaacs, Migraine in Patients With Inflammatory Bowel Disorders, Journal of Clinical Gastroenterology, 2009, 43, 5, 499

    CrossRef

  10. 10
    Daniel D. Hampton, Martin H. Poleski, Jane E. Onken, Inflammatory bowel disease following solid organ transplantation, Clinical Immunology, 2008, 128, 3, 287

    CrossRef

  11. 11
    Pascal Juillerat, Valérie Pittet, Christian Felley, Christian Mottet, Florian Froehlich, John-Paul Vader, Jean-Jacques Gonvers, Pierre Michetti, Drug Safety in Crohn’s Disease Therapy, Digestion, 2007, 76, 2, 161

    CrossRef

  12. 12
    Jean-Jacques Gonvers, Pascal Juillerat, Christian Mottet, Valérie Pittet, Christian Felley, John-Paul Vader, Pierre Michetti, Florian Froehlich, Maintenance of Medically Induced Remission of Crohn’s Disease, Digestion, 2007, 76, 2, 116

    CrossRef

  13. 13
    S. Palaniappan, A. C. Ford, D. Greer, S. M. Everett, D. M. Chalmers, A. T. R. Axon, P. J. Hamlin, Mycophenolate mofetil therapy for refractory inflammatory bowel disease, Inflammatory Bowel Diseases, 2007, 13, 12
  14. 14
    Gary R. Lichtenstein, Maria T. Abreu, Russell Cohen, William Tremaine, American Gastroenterological Association Institute Technical Review on Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel Disease, Gastroenterology, 2006, 130, 3, 940

    CrossRef

  15. 15
    Felix Braun, Matthias Behrend, Basic immunosuppressive drugs outside solid organ transplantation, Expert Opinion on Investigational Drugs, 2006, 15, 3, 267

    CrossRef

  16. 16
    Paul A Rufo, Athos Bousvaros, Current Therapy of Inflammatory Bowel Disease in Children, Pediatric Drugs, 2006, 8, 5, 279

    CrossRef

  17. 17
    Brian W Behm, Stephen J Bickston, Medical management of Crohn's disease: current therapy and recent advances, Expert Review of Clinical Immunology, 2006, 2, 1, 109

    CrossRef

  18. 18
    Jolanda M. van Dieren, Ernst J. Kuipers, Janneke N. Samsom, Edward E. Nieuwenhuis, C. Janneke van der Woude, Revisiting the immunomodulators tacrolimus, methotrexate, and mycophenolate mofetil: Their mechanisms of action and role in the treatment of IBD, Inflammatory Bowel Diseases, 2006, 12, 4
  19. 19
    M. Domínguez-Antonaya, Tratamiento de la enfermedad de Crohn corticodependiente y corticorrefractaria, FMC - Formación Médica Continuada en Atención Primaria, 2006, 13, 3, 150

    CrossRef

  20. 20
    Pascal Juillerat, Christian Felley, Christian Mottet, Florian Froehlich, John-Paul Vader, Bernard Burnand, Jean-Jacques Gonvers, Pierre Michetti, Drug Safety in the Treatment of Crohn’s Disease, Digestion, 2005, 71, 1, 8

    CrossRef

  21. 21
    Britta Siegmund, Martin Zeitz, Standards of medical treatment and nutrition in Crohn’s disease, Langenbeck's Archives of Surgery, 2005, 390, 6, 503

    CrossRef

  22. 22
    Gerald B. Appel, Jai Radhakrishnan, Ellen M. Ginzler, Use of Mycophenolate Mofetil in Autoimmune and Renal Diseases, Transplantation, 2005, 80, Supplement, S265

    CrossRef

  23. 23
    Conor G Loftus, Laurence J Egan, William J Sandborn, Cyclosporine, tacrolimus, and mycophenolate mofetil in the treatment of inflammatory bowel disease, Gastroenterology Clinics of North America, 2004, 33, 2, 141

    CrossRef

  24. 24
    R. Caprilli, E. Angelucci, A. Cocco, A. Viscido, M. Zippi, Efficacy of conventional immunosuppressive drugs in IBD, Digestive and Liver Disease, 2004, 36, 11, 766

    CrossRef

  25. 25
    H. H. Wenzl, T. A. Hinterleitner, B. W. Aichbichler, P. Fickert, W. Petritsch, Mycophenolate mofetil for Crohn's disease: short-term efficacy and long-term outcome, Alimentary Pharmacology & Therapeutics, 2004, 19, 4
  26. 26
    Severine Vermeire, Paul Rutgeerts, Novel biological strategies in inflammatory bowel diseases, Inflammatory Bowel Diseases, 2004, 10, 7
  27. 27
    Driffa Moussata, Stéphane Nancey, Bernard Flourié, Sylvette Claudel Bonvoisin, Jean-Claude Cenni, Louis Descos, Rectocolite ulcéro-hémorragique chronique active, La Presse Médicale, 2004, 33, 9, 590

    CrossRef

  28. 28
    Karl H. Kim, Gary R. Lichtenstein, Refractory inflammatory bowel disease, Current Treatment Options in Gastroenterology, 2004, 7, 3, 201

    CrossRef

  29. 29
    Jean-Marie Reimund, Bruno Bonaz, Michel Gompel, Francis Michot, Jacques Moreau, Michel Veyrac, Jacques Wagner Ballon, Traitement préventif de la rechute au cours de la rectocolite ulcéro-hémorragique, Gastroentérologie Clinique et Biologique, 2004, 28, 10, 992

    CrossRef

  30. 30
    Thomas A Judge, Gary R Lichtenstein, Treatment of fistulizing Crohn's disease, Gastroenterology Clinics of North America, 2004, 33, 2, 421

    CrossRef

  31. 31
    A.J. German, E.J. Hall, M.J. Day, Chronic Intestinal Inflammation and Intestinal Disease in Dogs, Journal of Veterinary Internal Medicine, 2003, 17, 1
  32. 32
    A. C. Ford, R. J. Towler, P Moayyedi, D. M. Chalmers, A. T. R. Axon, Mycophenolate mofetil in refractory inflammatory bowel disease, Alimentary Pharmacology & Therapeutics, 2003, 17, 11
  33. 33
    K. R. Herrlinger, P. Deibert, M. Schwab, W. Kreisel, C. Fischer, K. Fellermann, E. F. Stange, Remission maintenance by tioguanine in chronic active Crohn's disease, Alimentary Pharmacology & Therapeutics, 2003, 17, 12
  34. 34
    D. C. Baumgart, B. Wiedenmann, A. U. Dignass, Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease, Alimentary Pharmacology & Therapeutics, 2003, 17, 10
  35. 35
    Russell D. Cohen, Evolving medical therapies for ulcerative colitis, Current Gastroenterology Reports, 2002, 4, 6, 497

    CrossRef

  36. 36
    Y Quiroz, J Herrera-Acosta, R.J Johnson, B Rodriguez-Iturbe, Mycophenolate mofetil treatment in conditions different from organ transplantation, Transplantation Proceedings, 2002, 34, 7, 2523

    CrossRef

  37. 37
    Ali Keshavarzian, Ashkan Farhadi, Ece A Mutlu, New developments in the treatment of inflammatory bowel disease, Expert Opinion on Investigational Drugs, 2002, 11, 3, 365

    CrossRef

  38. 38
    Klaus Fellermann, Zita Tanko, Klaus R. Herrlinger, Thomas Witthoeft, Nils Homann, Andreas Bruening, Diether Ludwig, Eduard F. Stange, Response of refractory colitis to intravenous or oral tacrolimus (FK506), Inflammatory Bowel Diseases, 2002, 8, 5
  39. 39
    Maeve M. Skelly, Richard F. A. Logan, David Jenkins, Yashwant R. Mahida, Christopher J. Hawkey, Toxicity of mycophenolate mofetil in patients with inflammatory bowel disease, Inflammatory Bowel Diseases, 2002, 8, 2
  40. 40
    Matthias Behrend, Adverse Gastrointestinal Effects of Mycophenolate Mofetil, Drug Safety, 2001, 24, 9, 645

    CrossRef

  41. 41
    Russell D. Cohen, Intravenous cyclosporine in severe ulcerative colitis: Ready to stand alone?, Gastroenterology, 2001, 120, 6, 1541

    CrossRef

  42. 42
    DS Rampton, MF Neurath, S Almer, G D'Haens, W Petritsch, EF Stange, Mycophenolate mofetil in Crohn's disease, The Lancet, 2000, 356, 9224, 163

    CrossRef